Daxor Corporation Files Methods Patent For Blood Optimization Method

NEW YORK, NY -- (MARKET WIRE) -- February 12, 2007 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced it has filed for a patent for its Blood Optimization Program.
MORE ON THIS TOPIC